2 news items
HC Wainwright & Co. Initiates Coverage On Cyclo Therapeutics with Buy Rating, Announces Price Target of $3
CYTH
1 May 24
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces Price Target of $3.
Ascendiant Capital Initiates Coverage On Cyclo Therapeutics with Buy Rating, Announces Price Target of $2.6
CYTH
22 Apr 24
Ascendiant Capital analyst Lucas Ward initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces Price Target of $2.6.
- Prev
- 1
- Next